Simplex Trading, LLC Neu Base Therapeutics, Inc. Transaction History

Simplex Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	BUY	$0.17 - $0.39 $293 - $672	1,725 New	1,725 $0
Q3 2022 Nov 04, 2022	BUY	$0.41 - $1.3 $70 - $222	171 New	171 $0
Q2 2022 Aug 03, 2022	SELL	$0.82 - $1.93 $4,359 - $10,259	-5,316 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$1.26 - $2.95 $3,790 - $8,873	-3,008 Reduced 36.14%	5,316 $9,000
Q4 2021 Feb 23, 2022	BUY	$2.6 - $4.18 $8,920 - $14,341	3,431 Added 70.12%	8,324 $23,000
Q2 2021 Aug 12, 2021	SELL	$4.63 - $7.34 $53,045 - $84,094	-11,457 Reduced 70.07%	4,893 $23,000
Q1 2021 Apr 26, 2021	BUY	$6.92 - $12.36 $97,841 - $174,758	14,139 Added 639.48%	16,350 $120,000
Q4 2020 Feb 02, 2021	BUY	$6.92 - $9.25 $15,300 - $20,451	2,211 New	2,211 $15,000

Ticker NBSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,258,700
Description
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.